EUVIMEDEUVIMED entdecken
Open Access

Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β

Xin Fang, Yun Wang, Zhenli Long, Bin Liao, Bo Wang, Daojun Hong, Jie Luo, Tingtao Chen

Journal of Zhejiang University-SCIENCE B · 2026-08 · 27 (8) · 872-887

DOI: 10.1631/jzus.b2500237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Zhejiang University-SCIENCE B, online erschienen am 27.06.2026. Verfasst von Xin Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Clostridium butyricum, alpha-Synuclein, Proto-Oncogene Proteins c-akt, Glycogen Synthase Kinase 3 beta. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Jiangxi Provincial Natural Science Foundation, the Academic and Technical Leaders of Major Disciplines in Jiangxi Province, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridium butyricumalpha-SynucleinProto-Oncogene Proteins c-aktGlycogen Synthase Kinase 3 betaGlucagon-Like Peptide 1Parkinson DiseaseAnimalsMiceSignal TransductionMice, TransgenicDisease Models, AnimalPhosphatidylinositol 3-KinasesMaleNeuroprotectionMice, Inbred C57BLGastrointestinal MicrobiomeIntestinal Barrier Function

Stichwörter der Autor:innen

Clostridium butyricum-pMTL007-GLP-1Glucagon-like peptide-1 (GLP-1)Gut microbiotaPI3K/AKT/GSK-3β pathwayParkinson’s disease

Substanzen

alpha-SynucleinProto-Oncogene Proteins c-aktGlycogen Synthase Kinase 3 betaGlucagon-Like Peptide 1Phosphatidylinositol 3-KinasesGsk3b protein, mouse

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • Institute of Neurology, Jiangxi Academy of Clinical Medical Science, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • Rare Disease Center, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • Key Laboratory of Rare Neurological Diseases of Jiangxi Provincial Health Commission, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • School of Queen Mary, Nanchang University, Nanchang 330031, China.
  • School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. jieluo@ncu.edu.cn.

Förderung

  • the Jiangxi Provincial Natural Science Foundation
  • the Academic and Technical Leaders of Major Disciplines in Jiangxi Province
  • the National Natural Science Foundation of China

Zitieren

APA

Fang, X., Wang, Y., Long, Z., Liao, B., Wang, B., Hong, D., Luo, J., & Chen, T. (2026). Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β. Journal of Zhejiang University-SCIENCE B, 27(8), 872-887. https://doi.org/10.1631/jzus.b2500237

Vancouver

Fang X, Wang Y, Long Z, Liao B, Wang B, Hong D, et al. Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β. Journal of Zhejiang University-SCIENCE B. 2026;27(8):872-887. doi:10.1631/jzus.b2500237

BibTeX
@article{Fang2026,
  author = {Fang, Xin and Wang, Yun and Long, Zhenli and Liao, Bin and Wang, Bo and Hong, Daojun and Luo, Jie and Chen, Tingtao},
  title = {Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β},
  journal = {Journal of Zhejiang University-SCIENCE B},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {872--887},
  doi = {10.1631/jzus.b2500237}
}
Kostenlos starten →